帕金森病专科护理干预的成本效果:NICE-PD随机对照试验方案
本研究为一项在荷兰8家社区医院开展的18个月单盲随机对照试验,计划纳入240例近2年未接受过帕金森病专科护士(PDNS)治疗的帕金森病患者,按1:1随机分配至PDNS护理组或常规护理组,评估PDNS护理相比常规护理的成本效果,共同主要结局为生活质量(PDQ-39)和运动症状(MDS-UPDRS第三部分)。
要点
- 指南推荐所有帕金森病患者应可获得PDNS护理,但成本效果证据不足。
- 该试验采用单盲设计,共同主要结局为PDQ-39和MDS-UPDRS第三部分。
- 预设按病程(<5年、5-10年、>10年)进行亚组分析。
核心结论
- 该研究旨在评估PDNS提供的专科护理相比无PDNS的常规护理在帕金森病患者中的成本效果。
- 研究假设PDNS护理可提高生活质量,且因减少全科医生和神经科医生咨询而抵消额外护士成本,使医疗费用保持相等。
研究设计与样本
- 18个月、单盲、随机对照临床试验,在荷兰8家社区医院开展。
- 计划纳入240例帕金森病患者,近2年未接受过PDNS治疗,不限疾病严重程度或病程。
- 每家医院30例患者按1:1随机分配至PDNS护理组(遵循近期PDNS护理指南)或常规护理组。
关键数值与推荐
- 共同主要结局为生活质量(PDQ-39)和运动症状(MDS-UPDRS第三部分)。
- 次要结局包括非运动症状、健康相关生活质量、护理体验质量、自我管理、用药依从性、照护者负担和应对技能。
- 数据在12个月和18个月由盲法研究者收集,医疗利用和生产力损失问卷每3个月完成一次。
- 预设按病程(诊断<5年、5-10年、>10年)进行亚组分析。
临床怎么用
- 若结果支持PDNS护理具有成本效果,可为广泛实施PDNS护理提供依据。
局限性
- 试验注册为回顾性注册(2019年2月5日)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Current guidelines recommend that every person with Parkinson's disease (PD) should have access to Parkinson's disease nurse specialist (PDNS) care. However, there is little scientific evidence of the cost-effectiveness of PDNS care. This hampers wider implementation, creates unequal access to care, and possibly leads to avoidable disability and costs. Therefore, we aim to study the (cost-)effectiveness of specialized nursing care provided by a PDNS compared with usual care (without PDNS) for people with PD in all disease stages. To gain more insight into the deployed interventions and their effects, a preplanned subgroup analysis will be performed on the basis of disease duration (diagnosis < 5, 5-10, or > 10 years ago). METHODS: We will perform an 18-month, single-blind, randomized controlled clinical trial in eight community hospitals in the Netherlands. A total of 240 people with PD who have not been treated by a PDNS over the past 2 years will be included, independent of disease severity or duration. In each hospital, 30 patients will randomly be allocated in a 1:1 ratio to receive either care by a PDNS (who works according to a recent guideline on PDNS care) or usual care. We will use two co-primary outcomes: quality of life (measured with the Parkinson's Disease Questionnaire-39) and motor symptoms (measured with the Movement Disorders Society-sponsored revision of the Unified Parkinson's Disease Rating Scale part III). Secondary outcomes include nonmotor symptoms, health-related quality of life, experienced quality of care, self-management, medication adherence, caregiver burden, and coping skills. Data will be collected after 12 months and 18 months by a blinded researcher. A healthcare utilization and productivity loss questionnaire will be completed every 3 months. DISCUSSION: The results of this trial will have an immediate impact on the current care of people with PD. We hypothesize that by offering more patients access to PDNS care, quality of life will increase. We also expect healthcare costs to remain equal because increases in direct medical costs (funding additional nurses) will be offset by a reduced number of consultations with the general practitioner and neurologist. If these outcomes are reached, wide implementation of PDNS care will be warranted. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03830190. Registered February 5, 2019 (retrospectively registered).
引用
- Radder DLM, Lennaerts HH, Vermeulen H, et al. The cost-effectiveness of specialized nursing interventions for people with Parkinson's disease: the NICE-PD study protocol for a randomized controlled clinical trial. Trials. 2020. PMID: 31941538. doi:10.1186/s13063-019-3926-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。